Prognostic factors in brain metastases: can we determine patients who do not benefit from whole-brain radiotherapy?

@article{Lock2004PrognosticFI,
  title={Prognostic factors in brain metastases: can we determine patients who do not benefit from whole-brain radiotherapy?},
  author={Michael I. Lock and Edward Chow and Gregory R. Pond and Viet L. Do and Cyril Danjoux and Robert E Dinniwell and Jean Hedrick Lea and Andrea Bezjak},
  journal={Clinical oncology (Royal College of Radiologists (Great Britain))},
  year={2004},
  volume={16 5},
  pages={
          332-8
        }
}
AIMS Whole-brain radiotherapy (WBRT) is a standard treatment recommendation for patients with brain metastases. The goal of treatment is symptom control, which in the short run can be often achieved by steroids. Patients with a short life expectancy may not derive benefit from the addition of radiation. The ability to identify this group would aid the decision of whether to recommend WBRT. MATERIALS AND METHODS Data on all patients referred for WBRT to palliative radiotherapy teams at two… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

Similar Papers

Loading similar papers…